Estado actual de la diabetes en México y uso de la nanotecnología en los nuevos tratamientos con insulina
Palabras clave:
diabetes, insulina, nanotecnología, nanomaterialesResumen
Actualmente, los países de todo el mundo asignan grandes cantidades de recursos monetarios en el control de la diabetes mellitus y en las enfermedades relacionadas con el síndrome metabólico. Los países en vías de desarrollo, como México, factores como el estilo de vida sedentario y la desinformación en el control de la alimentación provocan una mayor incidencia en los casos de diabetes mellitus. Por este motivo, es necesario estudiar las tendencias actuales en cuanto a la diabetes mellitus, los factores que desencadenan el desorden metabólico y aquellos que lo empeoran. En este trabajo de revisión nos centramos en el estudio del estado actual de la diabetes en México, los tratamientos actuales y los avances que se tienen en el campo de la nanotecnología para la administración de fármacos.
Referencias
Abdelkader, D. H., El-Gizawy, S. A., Faheem, A. M., McCarron, P. A., & Osman, M. A. (2018). Effect of process variables on formulation, in-vitro characterisation and subcutaneous delivery of insulin PLGA nanoparticles: An optimisation study. Journal of Drug Delivery Science and Technology, 43: 160–171. https://doi.org/10.1016/J.JDDST.2017.10.004
Abeer, M. M., Meka, A. K., Pujara, N., Kumeria, T., Strounina, E., Nunes, R., Costa, A., Sarmento, B., Hasnain, S. Z., Ross, B. P., & Popat, A. (2019). Rationally Designed
Dendritic Silica Nanoparticles for Oral Delivery of Exenatide. Pharmaceutics, 11(8):
418. https://doi.org/10.3390/PHARMACEUTICS11080418
Alharithy, M. K., Alobaylan, M. M., Alsugair, Z. O., & Alswat, K. A. (2018). Impact of Family History of Diabetes on Diabetes Control and Complications. Endocrine Practice, 24(9): 773–779. https://doi.org/10.4158/EP-2018-0071
Bahman, F., Greish, K., & Taurin, S. (2019). Nanotechnology in Insulin Delivery for Management of Diabetes. Pharmaceutical Nanotechnology, 7(2): 113–128. https://doi.org/10.2174/2211738507666190321110721
Bao, X., Qian, K., & Yao, P. (2021). Insulin- and cholic acid-loaded zein/casein–dextran nanoparticles enhance the oral absorption and hypoglycemic effect of insulin. Journal of Materials Chemistry B, 9(31): 6234–6245. https://doi.org/10.1039/D1TB00806D
Barnes, J. A., Eid, M. A., Creager, M. A., & Goodney, P. P. (2020). Epidemiology and Risk of Amputation in Patients With Diabetes Mellitus and Peripheral Artery Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 40(8): 1808–1817. https://doi.org/10.1161/ATVBAHA.120.314595
Bellary, S., Kyrou, I., Brown, J. E., & Bailey, C. J. (2021). Type 2 diabetes mellitus in older adults: clinical considerations and management. Nature Reviews Endocrinology, 17(9): 534–548. https://doi.org/10.1038/s41574-021-00512-2
Bello-Chavolla, O. Y., Rojas-Martinez, R., Aguilar-Salinas, C. A., & Hernández-Avila, M. (2017). Epidemiology of diabetes mellitus in Mexico. Nutrition Reviews, 75(1): 4–12. https://doi.org/10.1093/NUTRIT/NUW030
Bhumkar, D. R., Joshi, H. M., Sastry, M., & Pokharkar, V. B. (2007). Chitosan Reduced Gold Nanoparticles as Novel Carriers for Transmucosal Delivery of Insulin. Pharmaceutical Research, 24(8): 1415–1426. https://doi.org/10.1007/S11095-007-
9257-9
Chai, Z., Dong, H., Sun, X., Fan, Y., Wang, Y., & Huang, F. (2020). Development of glucose oxidase-immobilized alginate nanoparticles for enhanced glucose-triggered insulin delivery in diabetic mice. International Journal of Biological Macromolecules, 159: 640–647. https://doi.org/10.1016/J.IJBIOMAC.2020.05.097
Chen, D., Fulcher, J., Scott, E. S., & Jenkins, A. J. (2022). Precision Medicine Approaches for Management of Type 2 Diabetes. Precision Medicine in Diabetes, 1–52. https://doi.org/10.1007/978-3-030-98927-9_1
Cosmi, F., Shen, L., Magnoli, M., Abraham, W. T., Anand, I. S., Cleland, J. G., Cohn, J. N., Cosmi, D., de Berardis, G., Dickstein, K., Franzosi, M. G., Gullestad, L., Jhund, P. S., Kjekshus, J., Køber, L., Lepore, V., Lucisano, G., Maggioni, A. P., Masson, S., … Latini, R. (2018). Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes. European Journal of Heart Failure, 20(5): 888– 895. https://doi.org/10.1002/EJHF.1146
Courtney, C. H., & Olefsky, J. M. (2007). Insulin resistance. Mechanisms of Insulin Action: Medical Intelligence Unit, 185–209. https://doi.org/10.1007/978-0-387-72204- 7_10/COVER
Deng, W., Xie, Q., Wang, H., Ma, Z., Wu, B., & Zhang, X. (2017). Selenium nanoparticles as versatile carriers for oral delivery of insulin: Insight into the synergic antidiabetic effect and mechanism. Nanomedicine: Nanotechnology, Biology and Medicine, 13(6): 1965–1974. https://doi.org/10.1016/J.NANO.2017.05.002
Dinnyes, A., Schnur, A., Muenthaisong, S., Bartenstein, P., Burcez, C. T., Burton, N., Cyran, C., Gianello, P., Kemter, E., Nemeth, G., Nicotra, F., Prepost, E., Qiu, Y., Russo, L., Wirth, A., Wolf, E., Ziegler, S., & Kobolak, J. (2020). Integration of nano- and biotechnology for beta-cell and islet transplantation in type-1 diabetes treatment. Cell Proliferation, 53(5): e12785. https://doi.org/10.1111/CPR.12785
Disanto, R. M., Subramanian, V., & Gu, Z. (2015). Recent advances in nanotechnology for diabetes treatment. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 7(4): 548–564. https://doi.org/10.1002/WNAN.1329
Djuric, O., Ottone, M., Vicentini, M., Venturelli, F., Pezzarossi, A., Manicardi, V., Greci, M., & Giorgi Rossi, P. (2022). Diabetes and COVID-19 testing, positivity, and mortality: A population-wide study in Northern Italy. Diabetes Research and Clinical Practice, 191: 110051. https://doi.org/10.1016/J.DIABRES.2022.110051
Dwivedi, P., Kumar Tekade, R., & Kumar Jain, N. (2013). Nanoparticulate Carrier Mediated Intranasal Delivery of Insulin for the Restoration of Memory Signaling in Alzheimer’s Disease. Current Nanoscience, 9(1): 46–55. https://doi.org/10.2174/157341313805117983
Esparza-Romero, J. (2021). Prevalencia y factores asociados a diabetes mellitus tipo 2 en población indígena de México: revisión sistemática. Revista M dica Del Instituto Mexicano Del Seguro Social, 58(3): 317-327.
https://doi.org/10.24875/rmimss.m20000036
Fonte, P., Araújo, F., Silva, C., Pereira, C., Reis, S., Santos, H. A., & Sarmento, B. (2015). Polymer-based nanoparticles for oral insulin delivery: Revisited approaches. Biotechnology Advances, 33(6): 1342–1354. https://doi.org/10.1016/J.BIOTECHADV.2015.02.010
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020). Pathophysiology of Type 2 Diabetes Mellitus. International Journal of Molecular Sciences, 21(17): 6275.
https://doi.org/10.3390/IJMS21176275
Gibbons, C. H. (2017). Treatment-Induced Neuropathy of Diabetes. Current Diabetes Reports, 17(12): 1–6. https://doi.org/10.1007/S11892-017-0960-6
Gómez-Peralta, F., Abreu, C., Cos, X., & Gómez-Huelgas, R. (2020). ¿Cuándo empieza la diabetes? Detección e intervención tempranas en diabetes mellitus tipo 2. Revista Clínica Española, 220(5): 305–314. https://doi.org/10.1016/J.RCE.2019.12.003
Gupta, R. (2017). Diabetes Treatment by Nanotechnology. Journal of Biotechnology & Biomaterials, 7: 268. https://doi.org/10.4172/2155-952x.1000268
Hadiya, S., Radwan, R., Zakaria, M., El-Sherif, T., Hamad, M. A., & Elsabahy, M. (2020). Nanoparticles integrating natural and synthetic polymers for in vivo insulin delivery. Https://Doi.Org/10.1080/10837450.2020.1832117, 26(1): 30–40.
https://doi.org/10.1080/10837450.2020.1832117
He, Y., Al-Mureish, A., & Wu, N. (2021). Nanotechnology in the Treatment of Diabetic Complications: A Comprehensive Narrative Review. Journal of Diabetes Research, 2021: 6612063. https://doi.org/10.1155/2021/6612063
He, Z., Liu, Z., Tian, H., Hu, Y., Liu, L., Leong, K. W., Mao, H. Q., & Chen, Y. (2018).
Scalable production of core–shell nanoparticles by flash nanocomplexation to enhance mucosal transport for oral delivery of insulin. Nanoscale, 10(7): 3307–3319. https://doi.org/10.1039/C7NR08047F
Heidarisasan, S., Ziamajidi, N., Karimi, J., & Abbasalipourkabir, R. (2018). Effects of insulin-loaded chitosan-alginate nanoparticles on RAGE expression and oxidative stress status in the kidney tissue of rats with type 1 diabetes. Iranian Journal of Basic Medical Sciences, 21(10): 1035. https://doi.org/10.22038/IJBMS.2018.28463.6899
Herrera, M. F., García-García, E., Arellano-Ramos, J. F., Madero, M. A., Aldrete-Velasco,
J. A., & Corvalá, J. A. L. (2018). Metabolic Surgery for the Treatment of Diabetes Mellitus Positioning of Leading Medical Associations in Mexico. Obesity Surgery, 28(11): 3474–3483. https://doi.org/10.1007/S11695-018-3357-Y/TABLES/7
Higaki, M., Kameyama, M., Udagawa, M., Ueno, Y., Yamaguchi, Y., Igarashi, R., Ishihara, T., & Mizushima, Y. (2006). Transdermal Delivery of CaCO3-Nanoparticles
Containing Insulin. Https://Home.Liebertpub.Com/Dia, 8(3): 369–374. https://doi.org/10.1089/DIA.2006.8.369
Hurtado, A. , M. D., & Collazo-Clavell, M. (2022). Surgical Management for Diabetes Remission. Precision Medicine in Diabetes, 217–231. https://doi.org/10.1007/978-3- 030-98927-9_11
IDF DIABETES ATLAS. (2021). IDF DIABETES ATLAS; International Diabetes Federation. https://www.ncbi.nlm.nih.gov/books/NBK581934/
Inchaurraga, L., Martínez-López, A. L., Martin-Arbella, N., & Irache, J. M. (2020). Zein- based nanoparticles for the oral delivery of insulin. Drug Delivery and Translational Research, 10(6): 1601–1611. https://doi.org/10.1007/S13346-020-00796-3
Ito, K., Ookawara, S., Ishibashi, K., Morishita, Y., & Seifalian, A. (2017). Transgene and islet cell delivery systems using nano-sized carriers for the treatment of diabetes mellitus, 8(1): 1341758. https://doi.org/10.1080/20022727.2017.1341758
Jamwal, S., Ram, B., Ranote, S., Dharela, R., & Chauhan, G. S. (2019). New glucose oxidase- immobilized stimuli-responsive dextran nanoparticles for insulin delivery. International Journal of Biological Macromolecules, 123: 968–978. https://doi.org/10.1016/J.IJBIOMAC.2018.11.147
Joshi, H. M., Bhumkar, D. R., Joshi, K., Pokharkar, V., & Sastry, M. (2006). Gold nanoparticles as carriers for efficient transmucosal insulin delivery. Langmuir, 22(1): 300–305. https://doi.org/10.1021/LA051982U/ASSET/IMAGES/MEDIUM/LA051982UN0000 1.GIF
Kesharwani, P., Gorain, B., Low, S. Y., Tan, S. A., Ling, E. C. S., Lim, Y. K., Chin, C. M.,
Lee, P. Y., Lee, C. M., Ooi, C. H., Choudhury, H., & Pandey, M. (2018). Nanotechnology based approaches for anti-diabetic drugs delivery. Diabetes Research and Clinical Practice, 136: 52–77. https://doi.org/10.1016/J.DIABRES.2017.11.018
Khursheed, R., Singh, S. K., Wadhwa, S., Kapoor, B., Gulati, M., Kumar, R., Ramanunny,
A. K., Awasthi, A., & Dua, K. (2019). Treatment strategies against diabetes: Success so far and challenges ahead. European Journal of Pharmacology, 862: 172625. https://doi.org/10.1016/J.EJPHAR.2019.172625
Lee, S., Zhou, J., Guo, C. L., Wong, W. T., Liu, T., Wong, I. C. K., Jeevaratnam, K., Zhang, Q., & Tse, G. (2021). Predictive scores for identifying patients with type 2 diabetes mellitus at risk of acute myocardial infarction and sudden cardiac death. Endocrinology, Diabetes & Metabolism, 4(3): e00240. https://doi.org/10.1002/EDM2.240
Lehrke, M., & Marx, N. (2017). Diabetes Mellitus and Heart Failure. The American Journal of Cardiology, 120(1): S37–S47. https://doi.org/10.1016/J.AMJCARD.2017.05.014
Li, D., Liu, Y., & Wu, N. (2022). Application progress of nanotechnology in regenerative medicine of diabetes mellitus. Diabetes Research and Clinical Practice, 190: 109966. https://doi.org/10.1016/J.DIABRES.2022.109966
López-Goerne, T., Padilla-Godínez, F. J., Pérez-Dávalos, L., Ramírez-Olivares, P., & Arellano, D. (2020). Nanobiocatalysts: Cu/TiO2-SiO2 Nanoparticles as Tissue- Regeneration Treatment for Diabetic Foot Ulcers: In Vivo Studies. Current Biotechnology, 9(3): 230–239. https://doi.org/10.2174/2211550109999201026085353
López-Goerne, T., Ramírez-Olivares, P., Pérez-Dávalos, L. A., Velázquez-Muñoz, J. A., & Reyes-González, J. (2019). Catalytic Nanomedicine. Cu/TiO2-SiO2 Nanoparticles as Treatment of Diabetic Foot Ulcer: A Case Report. Current Nanomedicine, 10(3): 290–
295. https://doi.org/10.2174/2468187309666190906121924
María De Los Ángeles Gutiérrez-Bernal, W., Berenice Hernández-Miranda, M., & Daniel Godínez-Tamay, E. (2022). Hábitos dietéticos en un grupo pacientes con Diabetes Mellitus tipo 2 del Estado de México Archivos En Medicina Familiar, 24(3): 171-175.
Marín-Peñalver, J. J., Martín-Timón, I., Sevillano-Collantes, C., & Cañizo-Gómez, F. J. del. (2016). Update on the treatment of type 2 diabetes mellitus. World Journal of Diabetes, 7(17): 354. https://doi.org/10.4239/WJD.V7.I17.354
Mesiha, M. S., Sidhom, M. B., & Fasipe, B. (2005). Oral and subcutaneous absorption of insulin poly(isobutylcyanoacrylate) nanoparticles. International Journal of Pharmaceutics, 288(2): 289–293. https://doi.org/10.1016/J.IJPHARM.2004.10.003
Mumuni, M. A., Kenechukwu, F. C., Ofokansi, K. C., Attama, A. A., & Díaz, D. D. (2020). Insulin-loaded mucoadhesive nanoparticles based on mucin-chitosan complexes for oral delivery and diabetes treatment. Carbohydrate Polymers, 229: 115506. https://doi.org/10.1016/J.CARBPOL.2019.115506
Muntoni, E., Marini, E., Ahmadi, N., Milla, P., Ghè, C., Bargoni, A., Capucchio, M. T., Biasibetti, E., & Battaglia, L. (2019). Lipid nanoparticles as vehicles for oral delivery of insulin and insulin analogs: preliminary ex vivo and in vivo studies. Acta Diabetologica, 56(12): 1283–1292. https://doi.org/10.1007/S00592-019-01403-9
Navarro-Flores, E., & Cauli, O. (2020). Quality of Life in Individuals with Diabetic Foot Syndrome. Endocrine, Metabolic & Immune Disorders - Drug Targets, 20(9): 1365– 1372. https://doi.org/10.2174/1871530320666200128154036
O. Vera-Cruz, A. (2021). Generación, movilización y uso del conocimiento en diabetes mellitus 2 en México (1st ed., Vol. 1). http://dcsh.xoc.uam.mx/repdig/index.php/libros- dcsh/produccion-economica/item/471-generacion-movilizacion-y-uso-del- conocimiento-en-diabetes-mellitus-2-en-mexico
Ohishi, M. (2018). Hypertension with diabetes mellitus: physiology and pathology.
Hypertension Research, 41(6): 389–393. https://doi.org/10.1038/s41440-018-0034-4
Pang, H., Huang, X., Xu, Z. P., Chen, C., & Han, F. Y. (2023). Progress in oral insulin delivery by PLGA nanoparticles for the management of diabetes. Drug Discovery Today, 28(1): 103393. https://doi.org/10.1016/J.DRUDIS.2022.103393
Perreault, L., Skyler, J. S., & Rosenstock, J. (2021). Novel therapies with precision mechanisms for type 2 diabetes mellitus. Nature Reviews Endocrinology, 17(6): 364–
377. https://doi.org/10.1038/s41574-021-00489-y
Rajabnezhad, S. (2017). Mucoadhesive Microspheres of Chitosan and Polyvinyl Alcohol as A Carrier for Intranasal Delivery of Insulin: In Vitro and In Vivo Studies. MOJ Bioequiv Availab, 3(2): 39-45. https://doi.org/10.15406/mojbb.2017.03.00030
Rastogi, R., Anand, S., & Koul, V. (2010). Electroporation of polymeric nanoparticles: an alternative technique for transdermal delivery of insulin. Drug Development and Industrial Pharmacy, 36(11): 1303–1311. https://doi.org/10.3109/03639041003786193
Santos, A., Magro, D. O., Evangelista-Poderoso, R., & Saad, M. J. A. (2021). Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications. Diabetology and Metabolic Syndrome, 13(1): 1–14. https://doi.org/10.1186/S13098-021-00639-2/FIGURES/6
Saravanan, S. S., Malathi, M. S., P.S.L., S., Selvasubramanian, S. S., Balasubramanian, B. S., & Pandiyan, P. v. (2017). Hydrophilic poly (ethylene glycol) capped poly (lactic-co- glycolic) acid nanoparticles for subcutaneous delivery of insulin in diabetic rats. International Journal of Biological Macromolecules, 95: 1190–1198. https://doi.org/10.1016/J.IJBIOMAC.2016.11.009
Shen, D., Yu, H., Wang, L., Khan, A., Haq, F., Chen, X., Huang, Q., & Teng, L. (2020). Recent progress in design and preparation of glucose-responsive insulin delivery systems. Journal of Controlled Release, 321: 236–258. https://doi.org/10.1016/J.JCONREL.2020.02.014
Shilo, M., Berenstein, P., Dreifuss, T., Nash, Y., Goldsmith, G., Kazimirsky, G., Motiei, M., Frenkel, D., Brodie, C., & Popovtzer, R. (2015). Insulin-coated gold nanoparticles as a new concept for personalized and adjustable glucose regulation. Nanoscale, 7(48): 20489–20496. https://doi.org/10.1039/C5NR04881H
Simos, Y. v., Spyrou, K., Patila, M., Karouta, N., Stamatis, H., Gournis, D., Dounousi, E., & Peschos, D. (2021). Trends of nanotechnology in type 2 diabetes mellitus treatment. Asian Journal of Pharmaceutical Sciences, 16(1): 62–76. https://doi.org/10.1016/J.AJPS.2020.05.001
Singh, R., Kazmi, I., Afzal, M., Imam, F., & Alharbi, K. S. (2019). Dietary phytochemicals and their potential effects on diabetes mellitus 2. Plant and Human Health: Pharmacology and Therapeutic Uses, 3: 65–86. https://doi.org/10.1007/978-3-030- 04408-4_4/COVER
Sonaje, K., Lin, K. J., Wey, S. P., Lin, C. K., Yeh, T. H., Nguyen, H. N., Hsu, C. W., Yen,
T. C., Juang, J. H., & Sung, H. W. (2010). Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH- Responsive nanoparticles vs. subcutaneous injection. Biomaterials, 31(26): 6849–6858. https://doi.org/10.1016/J.BIOMATERIALS.2010.05.042
Sudhakar, S., Chandran, S. V., Selvamurugan, N., & Nazeer, R. A. (2020). Biodistribution and pharmacokinetics of thiolated chitosan nanoparticles for oral delivery of insulin in vivo. International Journal of Biological Macromolecules, 150: 281–288. https://doi.org/10.1016/J.IJBIOMAC.2020.02.079
Tan, X., Liu, X., Zhang, Y., Zhang, H., Lin, X., Pu, C., Gou, J., He, H., Yin, T., Zhang, Y., & Tang, X. (2018). Silica nanoparticles on the oral delivery of insulin. Journal of Drug Targeting , 15(8): 805–820. https://doi.org/10.1080/17425247.2018.1503250
Tan, X., Yin, N., Liu, Z., Sun, R., Gou, J., Yin, T., Zhang, Y., He, H., & Tang, X. (2020).
Hydrophilic and Electroneutral Nanoparticles to Overcome Mucus Trapping and Enhance Oral Delivery of Insulin. Molecular Pharmaceutics, 17(9): 3177–3191. https://doi.org/10.1021/ACS.MOLPHARMACEUT.0C00223/SUPPL_FILE/MP0C00 223_SI_001
Tesch, G. H. (2017). Diabetic nephropathy – is this an immune disorder? Clinical Science, 131(16): 2183–2199. https://doi.org/10.1042/CS20160636
Vega, R. A., Wang, Y., Harvat, T., Wang, S., Qi, M., Adewola, A. F., Lee, D., Benedetti, E., & Oberholzer, J. (2010). Modified gold nanoparticle vectors: A biocompatible intracellular delivery system for pancreatic islet cell transplantation. Surgery, 148(4): 858–866. https://doi.org/10.1016/J.SURG.2010.07.036
Wang, X., Zheng, C., Wu, Z., Teng, D., Zhang, X., Wang, Z., & Li, C. (2009). Chitosan- NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 88(1): 150–161. https://doi.org/10.1002/JBM.B.31161
Wei, X., Duan, X., Zhang, Y., Ma, Z., Li, C., & Zhang, X. (2020). Internalization Mechanism of Phenylboronic-Acid-Decorated Nanoplatform for Enhanced Nasal Insulin Delivery. ACS Applied Bio Materials, 3(4): 2132–2139. https://doi.org/10.1021/ACSABM.0C00002/SUPPL_FILE/MT0C00002_SI_001.PDF
WHO. (2022, October 18). WHO. World Health Organization. ‘‘WHO Coronavirus Disease (COVID-19) Dashboard.”. https://covid19.who.int/
Woolcott, O. O., & Castilla-Bancayán, J. P. (2021). The effect of age on the association between diabetes and mortality in adult patients with COVID-19 in Mexico. Scientific Reports, 11(1): 1–10. https://doi.org/10.1038/s41598-021-88014-z
Yakaryılmaz, F. D., & Öztürk, Z. A. (2017). Treatment of type 2 diabetes mellitus in the elderly. World Journal of Diabetes, 8(6): 278. https://doi.org/10.4239/WJD.V8.I6.278
Zhang, Q., Shen, Z., & Nagai, T. (2001). Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats. International Journal of Pharmaceutics, 218(1–2): 75–80. https://doi.org/10.1016/S0378-5173(01)00614-7
Zhang, X., Zhang, H., Wu, Z., Wang, Z., Niu, H., & Li, C. (2008). Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics, 68(3): 526–534. https://doi.org/10.1016/J.EJPB.2007.08.009
Zhang, Y., Yu, J., Kahkoska, A. R., Wang, J., Buse, J. B., & Gu, Z. (2019). Advances in transdermal insulin delivery. Advanced Drug Delivery Reviews, 139: 51–70. https://doi.org/10.1016/J.ADDR.2018.12.006
Zhang, Z., Li, H., Xu, G., & Yao, P. (2018). Liver-targeted delivery of insulin-loaded nanoparticles via enterohepatic circulation of bile acids. Drug Delivery, 25(1): 1224– 1233. https://doi.org/10.1080/10717544.2018.1469685/SUPPL_FILE/IDRD_A_1469685_S M3189.DOCX
Zhao, Y. Z., Li, X., Lu, C. T., Xu, Y. Y., Lv, H. F., Dai, D. D., Zhang, L., Sun, C. Z., Yang,
W., Li, X. K., Zhao, Y. P., Fu, H. X., Cai, L., Lin, M., Chen, L. J., & Zhang, M. (2011).
Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy. Acta Diabetologica, 49(4): 315–
325. https://doi.org/10.1007/S00592-011-0356-Z
Zhu, W., Wu, Y., Meng, Y. F., Xing, Q., Tao, J. J., & Lu, J. (2018). Association of obesity and risk of diabetic retinopathy in diabetes patients: A meta-analysis of prospective cohort studies. Medicine, 97(32): e11807. https://doi.org/10.1097/MD.0000000000011807
